Recombinant Human C1QTNF5 Protein，His

FANCD2 is a crucial protein involved in the Fanconi anemia (FA) pathway, a critical DNA repair mechanism that maintains genomic stability. This pathway is essential for the repair of interstrand DNA cross-links, which can be induced by various agents, including certain chemotherapeutic drugs and environmental toxins. Mutations in the FANCD2 gene are associated with Fanconi anemia, a rare genetic disorder characterized by increased susceptibility to cancer, bone marrow failure, and specific congenital abnormalities. The study of recombinant FANCD2 protein is significant for understanding its role in DNA repair and the FA pathway. By producing and purifying recombinant FANCD2, researchers can investigate its functional properties, regulatory mechanisms, and interactions with other proteins involved in the DNA damage response. Furthermore, this research holds potential for developing targeted therapies for FA-related malignancies and improving the efficacy of chemotherapeutic regimens that rely on the proper functioning of the FA pathway. Advances in the characterization of FANCD2 not only enhance our understanding of DNA repair mechanisms but also contribute to the development of clinical strategies to combat cancers associated with Fanconi anemia. As such, recombinant FANCD2 research is pivotal in bridging basic science with therapeutic applications, offering insights that could lead to novel treatments for patients suffering from FA and other related conditions.